![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Clinical Trials
Incyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib as a Treatment for Patients with COVID-19 Associated Cytokine Storm
Incyte announced that the Phase 3 RUXCOVID study evaluating the safety and efficacy of ruxolitinib (Jakafi®), a JAK1/JAK2 inhibitor, plus standard-of-care (SoC) as a...
Clinical Trials
Novartis provides update on RUXCOVID study of ruxolitinib for hospitalized patients with COVID-19
Novartis announced that the Phase III RUXCOVID study evaluating ruxolitinib on top of standard of care (SoC) therapy compared to SoC treatment alone in...
Clinical Trials
Sinovac snags $515M investment to double COVID-19 vaccine capacity as phase 3 readout nears
As the various COVID-19 vaccines move closer to the finish line, their developers have been raising money from investors or through advance government purchases...
Clinical Trials
Lilly’s tirzepatide significantly reduced A1C and body weight in people with type 2 diabetes
Tirzepatide led to superior A1C and body weight reductions from baseline in adults with type 2 diabetes after 40 weeks of treatment in topline...
Clinical Trials
Roche partners with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials
Roche announced a partnership with Moderna Inc. to utilise the Elecsys® Anti-SARS-CoV-2 S antibody test in Moderna’s mRNA-1273 vaccine research trials. This will facilitate...
Clinical Trials
Kaneka Eurogentec will manufacture INOVIO’s DNA vaccine candidate against COVID-19
INOVIO has assembled a global coalition of collaborators, partners and funders to rapidly advance the development of INO-4800, a DNA vaccine against the novel...
Clinical Trials
Algernon completes patient enrollment in phase 2b/3 study of Ifenprodil to treat COVID-19
Algernon Pharmaceuticals, a clinical stage pharmaceutical development company, announced that the final patient has been enrolled in its multinational phase 2b/3 human study of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read